Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma

Clinical trial NCT06356883 · RECRUITING

Trial details

NCT number: NCT06356883
Sponsor: Université de Sherbrooke
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme Relapse

Start date: 2025-08-01
Primary completion: 2027-04-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.